ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 217 filers reported holding ABERDEEN STD GOLD ETF TR in Q1 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $800,030 | -22.5% | 45,225 | -19.6% | 0.32% | -3.1% |
| Q2 2023 | $1,032,853 | -4.4% | 56,225 | -1.7% | 0.33% | -14.2% |
| Q1 2023 | $1,079,836 | +18.9% | 57,225 | +10.1% | 0.38% | +6.1% |
| Q4 2022 | $908,003 | -13.2% | 51,975 | -20.9% | 0.36% | -8.0% |
| Q3 2022 | $1,046,000 | -8.5% | 65,725 | -0.4% | 0.39% | -6.7% |
| Q2 2022 | $1,143,000 | +0.9% | 65,975 | +8.2% | 0.42% | +34.1% |
| Q1 2022 | $1,133,000 | +0.4% | 60,975 | -5.1% | 0.31% | +7.2% |
| Q4 2021 | $1,128,000 | -24.1% | 64,225 | -27.2% | 0.29% | -32.7% |
| Q3 2021 | $1,487,000 | -8.3% | 88,225 | -7.5% | 0.43% | -11.9% |
| Q2 2021 | $1,621,000 | -35.1% | 95,415 | -37.4% | 0.49% | -45.1% |
| Q1 2021 | $2,499,000 | -6.1% | 152,385 | +4.7% | 0.89% | -22.4% |
| Q4 2020 | $2,660,000 | +0.5% | 145,525 | -0.2% | 1.15% | -15.7% |
| Q3 2020 | $2,647,000 | +372.7% | 145,885 | +346.1% | 1.36% | +292.2% |
| Q2 2020 | $560,000 | +13.1% | 32,700 | 0.0% | 0.35% | -22.2% |
| Q1 2020 | $495,000 | – | 32,700 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudock, Inc. | 1,147,876 | $18,825,000 | 5.89% |
| UBP Investment Advisors SA | 716,194 | $11,750,000 | 4.80% |
| swisspartners Ltd. | 305,000 | $5,011,000 | 4.07% |
| Darwin Wealth Management, LLC | 1,380,786 | $22,644,000 | 3.95% |
| Cypress Capital, LLC | 527,505 | $8,651,000 | 3.53% |
| Newman Dignan & Sheerar, Inc. | 430,281 | $7,057,000 | 2.56% |
| SimpliFi, Inc. | 318,301 | $5,220,000 | 2.44% |
| Allen Capital Group, LLC | 577,017 | $9,463,000 | 2.08% |
| Almanack Investment Partners, LLC. | 1,191,188 | $19,536,000 | 1.99% |
| American Money Management, LLC | 314,165 | $5,152,000 | 1.92% |